Table 3. Study Flow Chart

Period	Screening	Treatment Period				Follow-up
visit	Visit 1	Visit 2	Visit 3	Visit 4	Visit 5	If necessary
Day	-2 weeks ~Baseline	Baseline	8 weeks (±7days)	16 weeks (±7days)	24 weeks (±7days)
Informed consent	O
Demographics	O
Vital Signs	O	O	O	O	O	O
Medical history	O
Prior, concomitant or ongoing medication	O	O	O	O	O	O
Diabetes examination	O	O	O	O	O	O
Diagnostic criteria for alopecia	O
Eligibility Assessments	O
Shaving & Tattoo	O	O	O	O	O
Randomization		O
Product distribution		O	O	O
Photographing of hair loss areas		O	O	O	O
Phototrichogram		O	O	O	O
Subject evaluation			O	O	O
Investigator evaluation			O	O	O
Adverse event			O	O	O	O
Product Return/Compliance assessment			O	O	O